Invesco Ltd. Axonics, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Axonics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 36,537 shares of AXNX stock, worth $2.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,537

Previous 33,522 8.99%

Holding current value

$2.59 Million

Previous $2.25 Million 12.96%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$67.3 - $69.67 $202,909 - $210,055	3,015 Added 8.99%	36,537 $2.55 Million
Q2 2024 Aug 13, 2024	BUY	$66.47 - $69.65 $43,737 - $45,829	658 Added 2.0%	33,522 $2.25 Million
Q1 2024 May 14, 2024	SELL	$56.67 - $69.36 $102 Million - $124 Million	-1,791,982 Reduced 98.2%	32,864 $2.27 Million
Q4 2023 Feb 12, 2024	BUY	$49.38 - $63.75 $9.38 Million - $12.1 Million	189,862 Added 11.61%	1,824,846 $114 Million
Q3 2023 Nov 13, 2023	BUY	$48.64 - $62.51 $4.38 Million - $5.63 Million	90,132 Added 5.83%	1,634,984 $91.8 Million
Q2 2023 Aug 11, 2023	SELL	$47.99 - $60.21 $13 Million - $16.3 Million	-269,915 Reduced 14.87%	1,544,852 $78 Million
Q1 2023 May 12, 2023	SELL	$52.6 - $67.34 $6.04 Million - $7.73 Million	-114,800 Reduced 5.95%	1,814,767 $99 Million
Q4 2022 Feb 13, 2023	BUY	$59.56 - $76.6 $32.6 Million - $42 Million	547,886 Added 39.65%	1,929,567 $121 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $1.75 Million - $2.36 Million	30,153 Added 2.23%	1,381,681 $97.3 Million
Q2 2022 Aug 15, 2022	BUY	$39.5 - $64.42 $7.12 Million - $11.6 Million	180,185 Added 15.38%	1,351,528 $76.6 Million
Q1 2022 May 16, 2022	BUY	$43.74 - $62.76 $4.04 Million - $5.8 Million	92,445 Added 8.57%	1,171,343 $73.3 Million
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $28,405 - $41,662	568 Added 0.05%	1,078,898 $60.4 Million
Q3 2021 Nov 15, 2021	BUY	$59.21 - $78.66 $14.3 Million - $19 Million	241,568 Added 28.87%	1,078,330 $70.2 Million
Q2 2021 Aug 17, 2021	SELL	$51.39 - $66.9 $2.08 Million - $2.71 Million	-40,524 Reduced 4.62%	836,762 $53.1 Million
Q1 2021 May 17, 2021	BUY	$49.14 - $59.89 $6.75 Million - $8.23 Million	137,360 Added 18.56%	877,286 $52.5 Million
Q4 2020 Feb 16, 2021	BUY	$42.19 - $51.5 $3.48 Million - $4.24 Million	82,373 Added 12.53%	739,926 $36.9 Million
Q3 2020 Nov 16, 2020	BUY	$35.33 - $51.04 $22.5 Million - $32.6 Million	637,759 Added 3221.98%	657,553 $33.6 Million
Q2 2020 Aug 14, 2020	BUY	$22.91 - $39.83 $453,480 - $788,395	19,794 New	19,794 $695,000
Q3 2019 Nov 14, 2019	SELL	$26.92 - $42.41 $2 Million - $3.16 Million	-74,411 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$18.54 - $40.97 $1.38 Million - $3.05 Million	74,411 New	74,411 $3.05 Million

Others Institutions Holding AXNX

# of Institutions

235

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account